KR880005125A - 7-((m-치환된)페닐글리신)1-카바-1-데티아세팔로스포린 - Google Patents

7-((m-치환된)페닐글리신)1-카바-1-데티아세팔로스포린 Download PDF

Info

Publication number
KR880005125A
KR880005125A KR870011038A KR870011038A KR880005125A KR 880005125 A KR880005125 A KR 880005125A KR 870011038 A KR870011038 A KR 870011038A KR 870011038 A KR870011038 A KR 870011038A KR 880005125 A KR880005125 A KR 880005125A
Authority
KR
South Korea
Prior art keywords
compound
formula
hydrogen
pharmaceutically
carba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR870011038A
Other languages
English (en)
Korean (ko)
Inventor
데이비드 그레이 쿠퍼 로빈
알란 웨버 존
Original Assignee
마리 앤 터커
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마리 앤 터커, 일라이 릴리 앤드 캄파니 filed Critical 마리 앤 터커
Publication of KR880005125A publication Critical patent/KR880005125A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR870011038A 1986-10-03 1987-10-02 7-((m-치환된)페닐글리신)1-카바-1-데티아세팔로스포린 Withdrawn KR880005125A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91517386A 1986-10-03 1986-10-03
US06/915173 1986-10-03

Publications (1)

Publication Number Publication Date
KR880005125A true KR880005125A (ko) 1988-06-28

Family

ID=25435354

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870011038A Withdrawn KR880005125A (ko) 1986-10-03 1987-10-02 7-((m-치환된)페닐글리신)1-카바-1-데티아세팔로스포린

Country Status (17)

Country Link
EP (1) EP0266896B1 (cg-RX-API-DMAC10.html)
JP (1) JPS6396186A (cg-RX-API-DMAC10.html)
KR (1) KR880005125A (cg-RX-API-DMAC10.html)
CN (1) CN87107149A (cg-RX-API-DMAC10.html)
AT (2) ATE79119T1 (cg-RX-API-DMAC10.html)
BG (1) BG47034A3 (cg-RX-API-DMAC10.html)
DE (1) DE3780909T2 (cg-RX-API-DMAC10.html)
DK (1) DK518487A (cg-RX-API-DMAC10.html)
FI (1) FI874311L (cg-RX-API-DMAC10.html)
GR (1) GR3005920T3 (cg-RX-API-DMAC10.html)
HU (1) HU200179B (cg-RX-API-DMAC10.html)
IE (1) IE872646L (cg-RX-API-DMAC10.html)
IL (1) IL84051A0 (cg-RX-API-DMAC10.html)
NZ (1) NZ222015A (cg-RX-API-DMAC10.html)
PL (1) PL151703B1 (cg-RX-API-DMAC10.html)
PT (1) PT85850B (cg-RX-API-DMAC10.html)
ZA (1) ZA877398B (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327364A1 (en) * 1988-02-05 1989-08-09 Eli Lilly And Company Crystalline beta-lactam solvate
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
IL156445A0 (en) 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
KR20070120617A (ko) 2001-01-26 2007-12-24 쉐링 코포레이션 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
BRPI0208384B1 (pt) 2001-03-28 2016-05-31 Merck Sharp & Dohme síntese enantiosseletiva de compostos intermediários de azetidinona
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
EP1429756B1 (en) 2001-09-21 2006-11-22 Schering Corporation Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US20030236243A1 (en) * 2002-05-14 2003-12-25 Shoichet Brian K. Sterically-awkward beta-lactamase inhibitors
CA2504916A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
WO2004081002A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
DE602004018617D1 (de) 2003-03-07 2009-02-05 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2004081004A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
CN102144992B (zh) * 2011-03-10 2013-04-10 浙江大学 苯基甘氨酸衍生物制备对金黄色葡萄球菌有抑菌和杀菌活性的抗菌剂的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697515A (en) * 1963-02-18 1972-10-10 Ciba Geigy Corp Process for splitting the 7-n-acyl group from cephalosporin compounds
NO155548C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger.
JPS5672698A (en) * 1979-11-14 1981-06-16 Kyowa Hakko Kogyo Co Ltd Preparation of optically active cephalosporin analogue
NO155547C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Optisk aktive cefalosporin-analoge og salter derav samt fremgangsmaate for deres fremstilling.
JPS60174787A (ja) * 1984-02-21 1985-09-09 Kyowa Hakko Kogyo Co Ltd 3位置換カルバセフエム化合物
US4673737A (en) * 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof

Also Published As

Publication number Publication date
ATE79119T1 (de) 1992-08-15
BG47034A3 (bg) 1990-04-16
AT388377B (de) 1989-06-12
PT85850B (en) 1990-01-12
PL268034A1 (en) 1988-09-01
HUT45053A (en) 1988-05-30
DE3780909T2 (de) 1993-03-04
PL151703B1 (en) 1990-09-28
AU591811B2 (en) 1989-12-14
DE3780909D1 (en) 1992-09-10
EP0266896A1 (en) 1988-05-11
JPS6396186A (ja) 1988-04-27
FI874311A0 (fi) 1987-10-01
DK518487A (da) 1988-04-04
EP0266896B1 (en) 1992-08-05
ZA877398B (en) 1989-05-30
DK518487D0 (da) 1987-10-02
AU7926987A (en) 1988-04-14
GR3005920T3 (cg-RX-API-DMAC10.html) 1993-06-07
IL84051A0 (en) 1988-03-31
CN87107149A (zh) 1988-05-18
FI874311A7 (fi) 1988-04-04
IE872646L (en) 1988-04-03
HU200179B (en) 1990-04-28
FI874311L (fi) 1988-04-04
NZ222015A (en) 1989-10-27
ATA257587A (de) 1988-11-15
PT85850A (en) 1987-11-01

Similar Documents

Publication Publication Date Title
CA2331870A1 (fr) Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR880011142A (ko) 피페라지닐-헤테로 시클릭 화합물
EP0339237A3 (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
KR850003402A (ko) 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법
ATE59296T1 (de) Zusammensetzungen zur bekaempfung von toxaemia.
DE69215965D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
CA2399187A1 (en) Kahalalide compounds
IE792028L (en) Pyrroloazetidinones
ATE142641T1 (de) Neue peptid-verbindungen und verfahren zur herstellung davon
KR870007160A (ko) 신규의 디하이드로벤조푸란-및 크로만-카복스아미드 유도체, 그것의 제조 방법 및 신경이완제로서의 사용법
DE58904143D1 (de) Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
DE68928174D1 (de) Verfahren zur Herstellung von Cephemderivaten
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
KR880011112A (ko) 벤즈아제핀 설폰아미드 화합물
FI955085A0 (fi) Uudet diosmetiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
KR960706476A (ko) 인터류킨-1 활성 억제제로서의 신규한 벤젠설포닐아민 유도체(Novel benzen-esulfonylimine derivatives as inhibitors of lL-1 action)
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
AR026222A1 (es) Compuestos derivados de acido antranilico
BG88028A (bg) Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат
ATE343384T1 (de) Pharmazeutische zusammensetzungen enthaltend aminothiazole derivate zur behandlung von motorischen störungen des dickdarms
KR870006035A (ko) 신규 항균제 1-티에닐-4-옥소퀴놀린-3-카복실산 화합물의 제법
EP0233745A3 (en) Chemical compounds
ATE46172T1 (de) Verbindungen, diese enthaltende pharmazeutische zusammensetzungen und verfahren zur herstellung.
KR910006292A (ko) 방향족 산의 n-아자비시클로 [3.3.0] 옥탄 아미드

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19871002

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid